A new study led by York University, looking at the health data of nearly 15,000 people enrolled in a medically supervised ...

As the burden of obesity grows globally, the interest in weight loss drugs has also risen proportionately. While the ...

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

President Donald Trump's executive order directs pharmaceutical companies to lower their prices to levels closer to those ...

Ozempic for diabetes management is being widely talked about for its weight loss benefits. But it can also have side effects.

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...

Medications such as Wegovy, Mounjaro and Ozempic were found to have disease-prevention qualities beyond their weight-loss ...

The jab has already been hailed a breakthrough in the war on obesity. Now, US researchers have found those on the injections ...

TWO blockbuster weight loss just have been tested against each other for the first time in a head-to-head trial. There was a clear winner, which saw slimmers shed 20 per cent of their body weight.

Often used as a weight-loss treatment, drugs such as Wegovy and Mounjaro have helped more than 500,000 people shed the extra ...